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Abstract Molecular diversity in T-type Ca2+ channels is pro-
duced by expression of three genes, and alternative splicing of
those genes. Prompted by di¡erences noted between rat and
human Cav3.3 sequences, we searched for splice variants. We
cloned six variants, which are produced by splicing at exon 33
and exon 34. Expression of the variants di¡ered between brain
regions. The electrophysiological properties of the variants dis-
played similar voltage-dependent gating, but di¡ered in their
kinetic properties. The functional impact of splicing was inter-
related, suggesting an interaction. We conclude that alternative
splicing of the Cav3.3 gene produces channels with distinct
properties. ( 2002 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
T-type calcium channels are thought to play important
roles in neuronal activity, including activation of low-thresh-
old spikes that lead to burst ¢ring [1]. Molecular cloning and
expression studies have established the existence of three genes
encoding T-type channels. The third member of this family,
Cav3.3 (formerly K1I), has been cloned from both rat and
human sources [2^4]. Although all three Cav3 channels are
low voltage-activated, some studies have found that the vol-
tage dependence of activation and inactivation of Cav3.3
channels occurs at slightly more positive potentials [2,5,6].
Although the properties of recombinant Cav3.3 K1 subunits
expressed alone in 293 cells are slower than most native
T-type currents, similar kinetics have been described for
T-type currents in neurons isolated from the lateral habenula
[7], retina [8], and laterodorsal [9] and reticular nucleus of the
thalamus [10]. Prominent expression of Cav3.3 mRNA has
been detected in many of these brain regions [11], suggesting
that Cav3.3 channels mediate these currents. Slow T-type cur-
rents are thought to play an important role in sustained neu-
ronal ¢ring [5,10].
Alignment of rat and human Cav3.3 sequences led to the
suggestion that there were either cloning and/or errors in the
rat sequence that produced shifts in the reading frame [4]. We
have re-investigated the structure of the rat Cav3.3, and now
report the existence of alternative splice variants that encode
distinct carboxy-termini. These results indicate that the Cav3.3
gene is alternatively spliced in a brain region-speci¢c manner,
producing functionally distinct channels.
2. Materials and methods
2.1. Cloning of Cav3.3 cDNAs
A rat brain Vgt10 cDNA library (Clontech, Palo Alto, CA, USA)
was screened using nucleotides (nt) 5143^6197 of rat Cav3.3 (Gen-
Bank accession number AF086827 [2]). DNA sequences were deter-
mined at the University of Virginia Biomolecular Research Facility.
2.2. RNA isolation and RT-PCR
Total RNA was extracted from rat whole brain or indicated regions
(kindly donated by Dr. E. Talley). cDNA was synthesized from 1 Wg
total RNA with 5 WM random decamers, 0.5 mM each dNTP, 100 U
M-MLV reverse transcriptase, and 20 U SUPERaseWIn1 (Ambion,
Austin, TX, USA). Ampli¢cation reactions were performed in a Mas-
tercycler gradient (Eppendorf, Westbury, NY, USA) and contained
2.5 Wl cDNA, 0.4 WM each primer, 0.8 mM dNTPs and 0.6 U Taq
DNA polymerase (Eppendorf). After a 150 s denaturation step, reac-
tions were cycled 35 times using 25 s for denaturation (94‡C) and
annealing (62‡C), and V60 s/kb for extension (72‡C). PCR products
were cloned with the pCRII-TOPO kit (Invitrogen, Carlsbad, CA,
USA). PCR primers were 21 nt long, and reported positions refer
to GenBank accession number AF086827. Full-length v33 variants
were cloned using overlapping extension PCR and Vent DNA poly-
merase (New England Biolabs, Beverly, MA, USA). Full-length
cDNAs of each variant were constructed in two steps using fragments
generated by HindIII (3386), SpeI (5228), BspEI (5571), and EcoRI
(polylinker).
2.3. Electrophysiology
293 cells (human embryonic kidney, #CRL-1573, American Type
Culture Collection, Manassas, VA, USA) were transiently transfected
by the calcium phosphate method with plasmid DNAs encoding each
Cav3.3 variant and green £uorescent protein (5:1 ratio). Electrophys-
iological experiments were carried out using the whole cell con¢gura-
tion of the patch clamp technique as described previously [12]. Whole
cell Ca2þ currents were recorded using the following external solution
(in mM): 5 CaCl2, 155 tetraethyl ammonium (TEA) chloride, and
10 HEPES, pH adjusted to 7.4 with TEA-OH. The internal pipette
solution contained the following (in mM): 125 CsCl, 10 EGTA,
2 CaCl2, 1 MgCl2, 4 Mg-ATP, 0.3 Na3GTP, and 10 HEPES, pH
adjusted to 7.2 with CsOH. Series resistance values ranged between
2 and 8 M6 (4.4L 0.2, n=113) and were compensated between pro-
tocols to at least 70%. Average cell capacitance was 11.6L 0.6 pF
(n=113). The holding potential was 3100 mV. All experiments
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were performed at room temperature (V22‡C). Average data are
presented as meanLS.E.M. The results were obtained from 56 trans-
fections, and each construct was tested in at least four transfections.
Statistical tests included unpaired two-tailed Student’s t-test for com-
paring two data sets, and the F-test for comparing two models such as
single or double exponential ¢ts.
3. Results and discussion
3.1. Cloning
Alignment of the rat and human Cav3.3 sequences indicated
that there were shifts in the reading frame in the region en-
coding the carboxy-terminus [4]. As reported previously [6],
resequencing of the original rat Cav3.3 cDNA did not reveal
any errors that would explain the shorter carboxy-terminus
(Fig. 1A). Since the frame shift occurs at an intron/exon bor-
der of the human gene, we searched for alternatively spliced
variants. A rat brain cDNA library was screened, and ¢ve
recombinants were puri¢ed, subcloned, and sequenced. Com-
parison of their sequences to the rat Cav3.3a sequence re-
vealed the presence of two variants spliced at nt 5473. The
sequence of clone 6 contained 40 additional nucleotides not
found previously, while that of clone 2 contained 121 addi-
tional nucleotides. We refer to the original rat clone as
Cav3.3a, the clone 6 variant as Cav3.3b, and the clone 2 var-
iant as Cav3.3c. The deduced amino acid sequences of these
clones were aligned to the human Cav3.3 (Fig. 1A). Although
the nucleotide sequences of all three variants are identical
after the variant region, Cav3.3a is in a di¡erent reading frame
from either Cav3.3b or c, leading to a short carboxy-terminus.
In contrast, Cav3.3b has a long carboxy-terminus that is of
similar length, and shares 85% identity, with the full-length
human Cav3.3. Cav3.3c contains 40 additional amino acids,
but is otherwise identical to Cav3.3b. The rat a, b, and c
isoforms di¡er at the analogous position as the exon 33^34
border in the human gene, indicating that these variants are
produced by splicing to alternative 3P acceptor sites in exon 34
(Fig. 1B).
To determine the abundance and distribution of these
Cav3.3 variants, we designed PCR primers that £anked this
variant region (forward primer r4 at nt 5214, reverse primer r7
at nt 5505). The forward primer was located 5P to exon 33,
which has been reported to be alternatively spliced in human
[13]. If splicing of the two sites is independent, then six prod-
ucts are expected. PCR ampli¢cation of rat total brain cDNA
generated multiple DNA fragments of the expected sizes (Fig.
2A). The products were cloned, mapped by restriction en-
zymes, and representative clones were sequenced. Variants
were identi¢ed that encode a, b, and c isoforms that either
excluded (referred to as v33) or included the 5P end of exon
33. Since each variant produces a uniquely sized PCR product
(except for Cav3.3a and v33b; Fig. 2B), their expression can
be detected after agarose gel electrophoresis. Because the an-
nealing sites of the PCR primers are common among all var-
iants, product formation should only depend on the amount
Fig. 1. Carboxy-terminal splice variants of Cav3.3. A: Deduced amino acid sequences of rat Cav3.3 variants are aligned to the full-length hu-
man Cav3.3 (GenBank accession number AF393329 [12]). Intron/exon borders of the human gene are marked (P) [12,13]. Identical amino
acids are shown in uppercase in the human sequence. B: Diagrammatic representation of splicing events.
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of starting material and the number of cycles. Analysis of
PCR reactions run for varying cycles demonstrated that prod-
uct formation was linear between 25 and 35 cycles (Fig.
2C,D), indicating that the intensity of ethidium bromide-
stained bands correlated with the abundance of the mRNA
encoding each variant. Other quantitative methods would
have met with limited success because there are many prod-
ucts (Q-PCR) of similar size (RNase protection assays).
Therefore, we used 35 cycles to assay cDNA prepared from
various rat brain regions. The major product ampli¢ed from
all regions was Cav3.3b (Fig. 2E). The c isoform was detected
to a lower extent in all regions, showing an even weaker ex-
pression in olfactory bulb, pituitary, and pineal gland (Fig.
2F). PCR products representing the original Cav3.3a isoform
showed the weakest expression. Products representing the v33
variants were less abundant, indicating that splicing to the
internal acceptor site occurred in less than 30% of the tran-
scripts.
To con¢rm the abundance of each variant we subcloned the
PCR products from total brain mRNA and characterized
52 recombinants. The observed rank order of abundance
was the following: Cav3.3bECav3.3v33bvCav3.3cs
Cav3.3v33csCav3.3v33a. The ratio of both v33b to b and
v33c to c was approximately 1:4. These results are in good
agreement with those of the agarose gel analysis of the PCR
products.
Somewhat surprisingly none of these clones corresponded
to the Cav3.3a isoform that we [2] and others have cloned [3].
Comparison of the two published rat sequences reveals 72
nucleotide di¡erences, resulting in 32 changes in the deduced
amino acid sequence. Perhaps the most signi¢cant di¡erence
was that their cDNA lacked nine base pairs, leading to the
deletion of three amino acids in IIIS4. Since S4 regions are
known to play a key role in sensing voltage [14], this deletion
might explain why their channel gates at voltages that are
20 mV more negative than either our rat or the human
Fig. 2. Expression and distribution of the rat Cav3.3 splice variants. Ethidium bromide-stained agarose gels showing RT-PCR products ampli-
¢ed from rat total brain RNA using primers r4 and r7 (A,C,E). To correlate the bands ampli¢ed from rat brain, representative plasmids were
PCR ampli¢ed using the same primers. Negative controls included omission of reverse transcriptase from the cDNA synthesis reaction (3RT),
and omission of cDNA to the PCR reaction (3template). B: Relative electrophoretic mobility (Rf ) of the plasmid PCR products. C: Agarose
gel of RT-PCR products obtained by varying the number of cycles. D: PCR products shown in C were quantitated using the histogram func-
tion in Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA, USA). The band intensity in arbitrary units (a.u.) was plotted versus cycle num-
ber and ¢t by linear regression. E: PCR products ampli¢ed from various regions of rat brain. F: Ratio of Cav3.3b and c variants in each brain
region.
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Cav3.3 isoforms [4,12], although a contribution from the three
amino acid changes in IIS4 must also be considered [3]. To
test if this deletion was due to alternative splicing, we PCR
ampli¢ed total rat brain cDNA with primers £anking this
region (forward nt 3660, reverse nt 3730). A single product
of 91 bp was detected, indicating that most transcripts contain
the full IIIS4 sequence (data not shown).
PCR analysis of the human CACNA1I gene suggested the
presence of an exon (#9) encoding sequences not found in rat
Cav3.3a [13]. PCR (forward nt 1282, reverse nt 1530) of this
region using rat brain cDNA led to a single product, corre-
sponding in size to the original Cav3.3a (results not shown).
As a positive control we ampli¢ed from human fetal brain
cDNA and detected two transcripts of the expected size. We
conclude that the rat gene is not alternatively spliced at exon
9.
3.2. Electrophysiology
To test the functional consequences of alternative splicing
at both exons 33 and 34, full-length cDNAs were constructed
that harbored all six variants. All six isoforms led to the in-
duction of currents whose voltage dependence (I^V) was sim-
ilar to low threshold-activated T-type currents (Fig. 3A; Table
1). To quantitate the voltage dependence of activation, I^V
data were normalized to the peak observed in each cell, ¢t
with a Boltzmann equation modi¢ed to account for changes
in driving force [12], then averaged. The variants had similar
voltage dependence with the exception of Cav3.3v33b that
gated 3 mV more negative (Table 1).
Current traces could be ¢t well with two exponentials,
where one exponential describes channel activation, while
the second describes inactivation (Fig. 3B). Activation kinetics
for all variants were relatively slow at test potentials just
Fig. 3. Voltage-dependent gating of Cav3.3 currents. A: Current^voltage relationships of Ca2þ currents generated by Cav3.3b (O, n=13) and
Cav3.3v33b channels (R, n=8). B: Representative current traces from Cav3.3b and v33b variants evoked by depolarizing pulses to either 350
mV (above) or 310 mV (below). Dotted lines represent the ¢t of the current traces with two exponentials. Activation (C) and inactivation (E)
d values are plotted as a function of test potential for Cav3.3a (a, n=12), Cav3.3c (P, n=11), Cav3.3v33a (b, n=11), and Cav3.3v33c
(S, n=8). Activation (D) and inactivation (F) kinetics of each Cav3.3v33 variant divided by the kinetics of its respective Cav3.3 isoform:
Cav3.3v33a/Cav3.3a, a ; v33b/b, O ; and v33c/c, P. Only shown are data points that di¡ered signi¢cantly (P6 0.05).
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above threshold, but were faster at more depolarized poten-
tials, approaching a plateau above 310 mV (Fig. 3C). The
voltage-independent rate for the Cav3.3a, b, and c isoforms
was V4.5 ms, while all three v33 variants were slower, ap-
proaching 6.6 ms. The v33 variants of Cav3.3a and b were
1.4-fold slower at all test potentials, while the v33 variant of
Cav3.3c showed a bigger di¡erence at negative test potentials
(Fig. 3D). The kinetics of inactivation were also voltage-de-
pendent at negative voltages, but in this case the rate was
voltage-independent above 330 mV (Fig. 3E). The inactiva-
tion rate for all variants was similar during test pulses to 350
mV, while at higher test potentials the Cav3.3a, b, and c
variants approached a voltage-independent rate of 69 ms. In
contrast, the inactivation kinetics for all three v33 variants
were 1.5-fold slower (Fig. 3F), approaching a voltage-inde-
pendent rate of 96 ms (Fig. 3E). Although the v33 deletion
slowed activation and inactivation kinetics of the Cav3.3a, b,
and c variants, these e¡ects appear to be independent because
they occur at di¡erent voltages.
The kinetics of channel closing, or deactivation, were mea-
sured using a two-step protocol. Although this protocol gen-
erates substantial currents, they were well clamped as evi-
denced by the rise time of the tail current (0.20L 0.01 ms,
n=51). As described previously [6,12], Cav3.3 channels close
in a biexponential manner (Fig. 4A). At very negative repola-
rization potentials (63100 mV) all the splice variants be-
haved similarly, closing with an apparent d of 1 ms (Fig.
4B), while at less negative potentials Cav3.3b and c channels
closed more slowly than Cav3.3a. The Cav3.3v33a variant
closed with similar kinetics as the a isoform, and similar re-
sults were obtained with the v33 variants of b and c (Table 1).
Voltage-gated Ca2þ channels can inactivate at membrane
potentials that are more negative than the apparent threshold
for channel opening, indicating that channels can enter inac-
tive states directly from closed states [15,16]. Since the v33
variants inactivated more slowly at potentials where channels
can open, we also examined whether they inactivate more
slowly from closed states. Development of inactivation was
measured by holding the membrane potential at either 360
or 370 mV for varying durations, and available channels were
tested with a depolarizing pulse to 330 mV (Fig. 4C). As
reported previously [6], Cav3.3a channels inactivated in a
biexponential manner, and similar results were obtained
with all variants (Table 1). Each variant also showed a similar
voltage dependence in its steady-state inactivation (Fig. 4D;
Table 1).
Recovery from inactivation allows T-type channels to gen-
erate rebound bursts [1]. To measure the recovery that might
occur after a burst, we inactivated channels with a 0.5 s step
to 330 mV (Fig. 4E). We also measured the recovery that
might occur during an inhibitory postsynaptic potential that
precedes a burst; channels were inactivated with a 20 s step to
360 mV then allowed channels to recover at 390 mV (Fig.
4F). In both cases the time course of recovery was monoex-
ponential, with faster recovery from the short inactivating
pulse to 330 mV (Table 1). The Cav3.3a, b, and c isoforms
recovered with a similar time course, while all the v33 variants
were slower (Fig. 4E; Table 1). In contrast, all variants re-
covered from the long pulse at 360 mV with a similar time
course (Fig. 4F; Table 1).
We conclude that splice variation a¡ects transitions be-
tween channel states, with little e¡ect on the voltage depen-
dence of these transitions. A recent study of the human exon
33 variants reached a similar conclusion [17]. In contrast to
the present results, their v33 variant inactivated faster in Xe-
nopus oocytes, and they found few kinetic di¡erences when the
channels were expressed in 293 cells. Since the distal carboxy-
terminus modulates the e¡ect of the v33 variation, di¡erences
between the studies might be ascribed to their use of a trun-
cated channel (see [12]). Kinetic di¡erences between Cav3 iso-
forms have been suggested to have profound physiological
consequences for neuronal ¢ring [5], such that Cav3.3v33 var-
Table 1
Summary of electrophysiological properties of Ca2þ currents from rat Cav3.3 channels
Cav3.3a Cav3.3b Cav3.3c Cav3.3v33a Cav3.3v33b Cav3.3v33c
Peak of I^V curve (mV) 330 330 330 330 330 330
I density (pA/pF) 3127L 17 (12) 3147L 14 (13) 3121L 23 (11) 393L 14 (11) 3117L20 (8) 3131L 23 (8)
Activation
V1=2 (mV) 341.8 L 1.2 (12) 342.6L 0.5 (13) 341.7 L 1.2 (11) 342.3 L 0.7 (11) 345.3L 0.6 (8)** 341.2 L 0.4 (8)
Slope (k, mV) 5.8 L 0.3 (12) 5.8L 0.2 (13) 6.1 L 0.3 (11) 6.4 L 0.3 (11) 6.2L 0.2 (8) 6.3 L 0.2 (8)
Inactivation
V1=2 (mV) 372.4 L 0.8 (10) 372.6L 0.7 (9) 371.3 L 0.9 (9) 371.2 L 0.6 (8) 374.4L 0.9 (7) 372.6 L 0.5 (8)
Slope (k, mV) 35.1 L 0.1 (10) 35.1L 0.2 (9) 35.1 L 0.2 (9) 35.6 L 0.3 (8) 35.5L 0.2 (7) 36.0 L 0.2 (8)**
Current kinetics at 340
Activation (d ; ms) 25.9 L 2.2 (12) 33.0L 4.4 (13) 27.1 L 3.8 (11) 38.3 L 3.9 (11)* 41.5L 7.4 (8) 53.5 L 8.4 (8)**
Inactivation rate (d ; ms) 96L 6 (12) 77L 4 (13)** 89L 7 (11) 126L 9 (11)* 111L 18 (8)* 111L 13 (8)
Current kinetics at +10
Activation (d ; ms) 3.7 L 0.2 (12) 3.8L 0.2 (13) 4.0 L 0.2 (11) 5.5 L 0.3 (11)** 5.1L 0.2 (8)** 6.2 L 0.6 (8)**
Inactivation rate (d ; ms) 72L 2 (12) 71L 4 (13) 68L 4 (11) 101L 4 (11)** 98L 8 (8)** 100L 10 (8)**
Deactivation kinetics at 390 (ms)a 1.6 L 0.1 (10) 1.9L 0.2 (8) 1.8 L 0.2 (8) 1.7 L 0.1 (7) 2.3L 0.1 (10) 2.3 L 0.3 (6)
Development of inactivation at 370
d1 (ms) 235L 58 (7) 231L 56 (6) 170L 30 (6) 125L 58 (6) 204L 46 (7) 227L 41 (6)
d2 (s) 1.8 L 0.1 (7) 1.7L 0.2 (6) 1.9 L 0.1 (6) 1.8 L 0.2 (6) 2.2L 0.2 (7) 2.2 L 0.1 (6)
Development of inactivation at 360
d1 (ms) 280L 31 (9) 348L 25 (5) 322L 23 (9) 332L 40 (7) 394L 55 (6) 343L 40 (7)
d2 (s) 1.6 L 0.1 (9) 1.9L 0.3 (5) 1.7 L 0.1 (9) 2.0 L 0.1 (7) 1.9L 0.2 (6) 1.9 L 0.2 (7)
Recovery from fast inactivation (ms) 238L 13 (8) 236L 13 (6) 237L 14 (7) 314L 14 (6)** 412L 16 (8)** 360L 17 (9)**
Recovery from deep inactivation (ms) 502L 27 (7) 503L 13 (7) 525L 22 (8) 469L 13 (6) 569L 20 (8)* 557L 21 (7)
aWeighted d.
Statistically signi¢cant di¡erences are noted if the P value was 6 0.05 (*) or 6 0.01 (**). Data are expressed as mean valuesL S.E.M. The
number of cells is presented in parentheses.
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Fig. 4. Deactivation and inactivation kinetics of Cav3.3 channels. A: Representative tail currents evoked upon repolarization of the membrane
to 370 mV after a 10 ms pulse to +60 mV. Dotted lines represent the ¢t of the tail current with two exponentials. Vertical scale bar: 4 nA for
Cav3.3a, and 5.8 nA for Cav3.3v33b. B: Deactivation kinetics. Points show the average weighted d [12] at each repolarization potential for
Cav3.3a (a, n=10), Cav3.3b (O, n=8), and Cav3.3v33b channels (R, n=10). C: Development of inactivation. Cells expressing Cav3.3b (open
symbols) or Cav3.3v33b (closed symbols) were held at either 360 (O, R) or 370 mV (E, F), for varying times, and then the available current
was tested at 330 mV. D: Voltage-dependent steady-state inactivation. Channels were inactivated by a 15 s conditioning pulse to di¡erent po-
tentials, then tested for channel availability with a 300 ms pulse to 330 mV. Each experimental data set was normalized to the peak current
obtained after the 3110 mV prepulse, then ¢t to a Boltzmann function. Average steady-state inactivation curves for Cav3.3b (O, n=9) and
Cav3.3v33b (R, n=7) are shown. E: Recovery from fast inactivation. Cav3.3b (O, n=6) and Cav3.3v33b (R, n=8) channels were inactivated
by a 500 ms pulse to 330 mV, and then channel availability was tested with a second pulse after an interpulse of variable duration. Recovery
was de¢ned as the ratio between the amplitude of the recovered current divided by the current elicited during the inactivating pulse. Channels
were allowed to recover for 10 s between episodes. Each data set was ¢t with an exponential, and then averaged. F: Recovery from deep inac-
tivation. Cav3.3 channels were inactivated by holding the membrane at 360 mV for 20 s, allowed to recover at 390 mV for variable times,
then tested for recovery with a pulse to 320 mV. Average data sets from Cav3.3b (O, n=7) and from Cav3.3v33b (R, n=8) were ¢t with a
single exponential.
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iants with slower inactivation might give rise to more sus-
tained ¢ring patterns.
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